PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/2643/10/13
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pharmaxis
An anonymous complainant (contractor to client) alleged weaknesses in Pharmaxis’ approval/certification systems and Code training.Pharmaxis marketed Bronchitol (mannitol) for cystic fibrosis (UK …
Clauses: NONE
🔒 Subscribers only
AUTH/2614/6/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Allergan market research
A health professional (and ex-Allergan employee) complained about an online “market research” survey his wife (a nurse) was invited to complete about injecting botulinum toxins.The survey refer…
🔒 Subscribers only
AUTH/2676/11/13
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Janssen
An anonymous, contactable member of the public complained about a published transparency study: “Clinical Trial Transparency: an assessment of the disclosure results of company-sponsored trials a…
Clauses: NONE
🔒 Subscribers only
AUTH/2674/11/13
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, contactable member of the public complained about a published transparency study: “Clinical Trial Transparency: an assessment of the disclosure results of company-sponsored trials a…
Clauses: NONE
🔒 Subscribers only
AUTH/2673/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Recordati
An anonymous, contactable member of the public complained about alleged late/non-disclosure of clinical trial results, based on an ABPI-funded transparency study published in Current Medical Resear…
Clauses: NONE
🔒 Subscribers only
AUTH/2672/11/13
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Merck Sharp & Dohme
An anonymous, contactable member of the public complained about alleged non-disclosure or non-timely disclosure of clinical trial results, based on an ABPI-funded transparency study published in Cu…
Clauses: NONE
🔒 Subscribers only
AUTH/2671/11/13
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Servier
An anonymous, contactable member of the public complained about clinical trial disclosure performance reported in an ABPI-funded paper in Current Medical Research & Opinion (published 11 Nov 20…
Clauses: NONE
🔒 Subscribers only
AUTH/2670/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka
An anonymous, contactable member of the public complained about alleged non-disclosure of clinical trial results for Samsca (tolvaptan), based on a transparency assessment published in Current Medi…
Clauses: NONE
🔒 Subscribers only
AUTH/2669/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shire
An anonymous, contactable member of the public complained about alleged non-disclosure of clinical trial results for Resolor (prucalopride), based on an ABPI-funded transparency study published in …
Clauses: NONE
🔒 Subscribers only
AUTH/2667/11/13
Social Media & Digital Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Amgen
An anonymous, contactable member of the public complained about clinical trial disclosure performance referenced in an ABPI-funded paper: Clinical Trial Transparency: an assessment of the disclosur…
Clauses: NONE
🔒 Subscribers only
AUTH/2666/11/13
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Sanofi
An anonymous, contactable member of the public complained about clinical trial disclosure performance referenced in an ABPI-funded study published in Current Medical Research & Opinion (11 Nov …
Clauses: NONE
🔒 Subscribers only
AUTH/2664/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Takeda
An anonymous, contactable member of the public complained about an ABPI-funded publication on clinical trial transparency (published in Current Medical Research & Opinion, 11 November 2013).The…
Clauses: NONE
🔒 Subscribers only
AUTH/2663/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Pierre Fabre
An anonymous, contactable member of the public complained about alleged non-disclosure of clinical trial results, based on a transparency assessment published in Current Medical Research & Opin…
Clauses: NONE
🔒 Subscribers only
AUTH/2662/11/13
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis
An anonymous, contactable member of the public complained about a published transparency assessment (“Clinical Trial Transparency…”) in Current Medical Research & Opinion (11 Nov 2013), s…
Clauses: NONE
🔒 Subscribers only
AUTH/2659/11/13
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pfizer
An anonymous, contactable member of the public complained about alleged non-disclosure/late disclosure of clinical trial results, based on a published transparency assessment in Current Medical Res…
Clauses: NONE
🔒 Subscribers only
AUTH/2657/11/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
AstraZeneca
An anonymous, contactable member of the public complained about alleged non-disclosure of clinical trial results, referencing a transparency study published in Current Medical Research & Opinio…
Clauses: NONE
🔒 Subscribers only
AUTH/2589/3/13
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor Pharma UK
Pharmacosmos A/S complained about a Vifor Pharma UK advertisement for Ferinject (ferric carboxymaltose) (ref UK/FER/12/0163c) published in Gastrointestinal Nursing, January 2013.The ad showed a lea…
Clauses: NONE
🔒 Subscribers only
AUTH/2579/2/13
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Bayer
A GP complained he was misled into attending a meeting he believed would provide hands-on training to fit Mirena using the new EvoInserter insertion device.The Mirena online training material said …
Clauses: NONE
🔒 Subscribers only
AUTH/2578/2/13
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Journalist v Novartis
A journalist complained that a Daily Mail Online article (“Don’t scrap asthma jab that saved my son’s life”, published 11 February 2013) was thinly veiled promotion of Xolair (omalizumab), …
Clauses: NONE
🔒 Subscribers only
AUTH/2577/2/13
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
AbbVie
AbbVie voluntarily admitted that out-of-date prescribing information (PI) was linked to an online Humira (adalimumab) banner ad (ref AXHUR111644a) and included in a hard copy journal ad (ref AXHUR1…
Clauses: 4.1
🔒 Subscribers only
AUTH/2609/6/13
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Roche
Roche Products Limited voluntarily advised the PMCPA that one promotional employee (a “relations manager”) had not taken the ABPI Medical Representatives Examination.The employee moved from a n…
Clauses: NONE
🔒 Subscribers only
AUTH/2601/5/13
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Gedeon Richter breached an undertaking after a meeting invitation stayed live online without prescri
An ex-employee alleged that a meeting invitation available on an events company’s website (seen 22 May 2013) breached an undertaking Gedeon Richter had given on 15 April 2013 in an earlier case (…
🔒 Subscribers only
AUTH/2595/4/13
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Lilly
Not stated (no case details were included in the provided CASE_TEXT beyond the source URL and case reference).
Clauses: NONE
🔒 Subscribers only
AUTH/2511/6/12
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Novartis
An anonymous complainant raised a complaint about Novartis tweets used for press releases.The PMCPA considered whether the matter fell within the scope of the ABPI Code of Practice.
Clauses: NONE
← Prev 22 23 24 25 26 27 28 Next → Page 25 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews